Opposition parties divided over ways to protest demonetisation

Mandya, Feb 9: A youth from Arechakanahalli village of Maddur taluk on Saturday allegedly committed suicide in Bengaluru after his lover got engaged to another man.

The body of the deceased, Darshan, was found hanging from the celising of his room in Bengaluru. According to Darshan's relatives, he was in love with a girl for the past few years.

Darshan had wanted to marry her, much to the chagrin of her parents, it is said.

The girl's parents had allegedly warned him of dire consequences if he did not stay clear from their daughter. In the meanwhile, she got engaged to another man.

Feeling left out, Darshan allegedly ended his life. In the suicide note, Darshan has held his lover and some of her relatives responsible for his death. He has also claimed that his family was facing death threat from her family.

There are rumours that Darshan might have been killed after he refused to stop seeing the girl. Though both the families are from the same community, their financial status, sources said, is different.

According to the relative of Darshan, the girl is a close relative to a former minister from Mandya district.

"There are reasons to suspect that Darshan might have been murdered, and a suicide note may have been planted at the crime spot.

A proper investigation should be conducted to unearth the truth," he said.

Shivamogga, Jun 16: The Deputy Commissioner on Tuesday announced a ban on movement of heavy goods vehicles in the Agumbe ghat section between June 15 and October 15 as a precautionary measure, as there was possibility of landslides due to heavy rain during the monsoon season.

All trucks over 12 tonnes will be prohibited from passing through the ghat, DC K B Shivakumar said in a statement here.

The authorities have suggested two alternative routes for the movement of heavy freight vehicles – the Shimoga-Thirthahalli-Sringeri-Kerekatte-Karkala-Udupi-Mangaluru route and the Shimoga-Thirthahalli-Mastikette-Hulikal-Hosangadi-Siddapura-Udupi-Mangaluru route.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.